- Home
- CTRM vs MIRA Comparison
CTRM vs MIRA Comparison
Compare CTRM & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- MIRA
- Stock Information
- Founded
- CTRM 2016
- MIRA 2020
- Country
- CTRM Cyprus
- MIRA United States
- Employees
- CTRM N/A
- MIRA N/A
- Industry
- CTRM Marine Transportation
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- CTRM Consumer Discretionary
- MIRA Health Care
- Exchange
- CTRM Nasdaq
- MIRA Nasdaq
- Market Cap
- CTRM 22.9M
- MIRA 19.5M
- IPO Year
- CTRM N/A
- MIRA 2023
- Fundamental
- Price
- CTRM $2.13
- MIRA $1.25
- Analyst Decision
- CTRM
- MIRA Strong Buy
- Analyst Count
- CTRM 0
- MIRA 2
- Target Price
- CTRM N/A
- MIRA $14.00
- AVG Volume (30 Days)
- CTRM 77.7K
- MIRA 175.1K
- Earning Date
- CTRM 08-07-2025
- MIRA 08-12-2025
- Dividend Yield
- CTRM N/A
- MIRA N/A
- EPS Growth
- CTRM N/A
- MIRA N/A
- EPS
- CTRM 0.38
- MIRA N/A
- Revenue
- CTRM $66,243,379.00
- MIRA N/A
- Revenue This Year
- CTRM N/A
- MIRA N/A
- Revenue Next Year
- CTRM N/A
- MIRA N/A
- P/E Ratio
- CTRM $5.56
- MIRA N/A
- Revenue Growth
- CTRM N/A
- MIRA N/A
- 52 Week Low
- CTRM $1.98
- MIRA $0.51
- 52 Week High
- CTRM $5.49
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- CTRM 42.49
- MIRA 46.62
- Support Level
- CTRM $2.09
- MIRA $1.15
- Resistance Level
- CTRM $2.33
- MIRA $1.30
- Average True Range (ATR)
- CTRM 0.14
- MIRA 0.08
- MACD
- CTRM -0.03
- MIRA -0.01
- Stochastic Oscillator
- CTRM 12.77
- MIRA 21.43
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.